Since AFPE showed neuroprotective properties [32], we analyzed the ability of Peaks 1–4 to affect the activity of AChE and BuChE, key enzymes involved in AD and PD, using in vitro enzyme assays that were performed in the absence or in the presence of the samples. Here, ACHE is linked to Parkinson disease.